Pfizer Inc.
Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation

Abstract:

The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.